[Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination].
Ducreux
M
M
Service des Maladies du Foie et de l'Appareil Digestif, Hôpital de Bicêtre.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D012004:Rectal Neoplasms / Q000628:therapy*; D012673:Semustine / Q000627:therapeutic use*
D012673:Semustine; D007978:Levamisole; D005472:Fluorouracil
Traitement adjuvant des cancers du côlon réséqués par association 5 fluoro-uracile-lévamisole.